Chitosan microspheres as a potential carrier for drugs
As discussed in the CY 2026 OPPS/ASC proposed rule, we intend to provide an opportunity for the public to review the data we collect prior to use of these data in a market-based relative weight methodology
Molina Healthcares commercial payment policy, which cites both A58777 and A56681, applies its own aggregation: no more than 4 sessions per spinal region in a rolling 12-month period across 62321, 62323, 64479, 64480, 64483, and 64484
But months later, when elbow pain became unbearable, he returned to that South Carolina physician and got an injection at the pain site
The FDA is reconsidering its 2023 ban on certain injectable peptides with advisory review starting in July, opening the door to compounding if cleared
Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies